Poly(ADP-ribose)polymerase-1 (PARP-1) is an important target for drug design for several therapeutic applications. 5-Aminoisoquinolin-1-one (5-AIQ) is a highly water-soluble lead compound; synthetic routes to 3-substituted analogues were explored. Tandem Hurtley coupling of β-diketones with 2-bromo-3-nitrobenzoic acid, retro-Claisen acyl cleavage and cyclisation gave the corresponding 3-substituted 5-nitroisocoumarins. Treatment with ammonia at high temperature and reduction with tin(II) chloride gave eleven target 3-substituted 5-AIQs, which were all soluble in water (>1% w/v) as their HCl salts. Most were more potent than 5-AIQ as inhibitors of PARP-1 and of PARP-2 in vitro, the most active being 5-amino-3-methylisoquinolin-1-one (PARP-1: IC50 = 0.23 M vs IC50 = 1.6 M for 5-AIQ). Some rationalisation of the SAR was achieved through molecular modelling.
|Number of pages||10|
|Journal||Bioorganic and Medicinal Chemistry|
|Publication status||Published - 1 Sep 2013|
- Hurtley reaction
FingerprintDive into the research topics of 'One-pot tandem Hurtley–retro-Claisen–cyclisation reactions in the synthesis of 3-substituted analogues of 5-aminoisoquinolin-1-one (5-AIQ), a water-soluble inhibitor of PARPs'. Together they form a unique fingerprint.
MC2- Nuclear Magnetic Resonance (NMR)Material and Chemical Characterisation (MC2)
Facility/equipment: Technology type